ABBV vs. ADI
Compare and contrast key facts about AbbVie Inc. (ABBV) and Analog Devices, Inc. (ADI).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ABBV or ADI.
Correlation
The correlation between ABBV and ADI is 0.44, which is considered to be moderate. This suggests that the two assets have some degree of positive relationship in their price movements. Moderate correlation can be acceptable for portfolio diversification, offering a balance between risk and potential returns.
Performance
ABBV vs. ADI - Performance Comparison
Key characteristics
ABBV:
0.73
ADI:
0.02
ABBV:
0.99
ADI:
0.37
ABBV:
1.15
ADI:
1.05
ABBV:
0.88
ADI:
0.04
ABBV:
2.15
ADI:
0.12
ABBV:
8.44%
ADI:
11.39%
ABBV:
27.49%
ADI:
42.26%
ABBV:
-45.09%
ADI:
-82.88%
ABBV:
-13.55%
ADI:
-16.47%
Fundamentals
ABBV:
$351.09B
ADI:
$98.50B
ABBV:
$2.34
ADI:
$3.14
ABBV:
84.82
ADI:
63.25
ABBV:
0.42
ADI:
0.83
ABBV:
6.05
ADI:
10.29
ABBV:
105.59
ADI:
2.76
ABBV:
$57.37B
ADI:
$7.18B
ABBV:
$44.44B
ADI:
$3.97B
ABBV:
$16.33B
ADI:
$3.18B
Returns By Period
In the year-to-date period, ABBV achieves a 6.39% return, which is significantly higher than ADI's -4.14% return. Over the past 10 years, ABBV has outperformed ADI with an annualized return of 15.79%, while ADI has yielded a comparatively lower 14.85% annualized return.
ABBV
6.39%
6.62%
-5.71%
19.87%
22.17%
15.79%
ADI
-4.14%
22.09%
-10.21%
0.66%
15.17%
14.85%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ABBV vs. ADI — Risk-Adjusted Performance Rank
ABBV
ADI
ABBV vs. ADI - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for AbbVie Inc. (ABBV) and Analog Devices, Inc. (ADI). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ABBV vs. ADI - Dividend Comparison
ABBV's dividend yield for the trailing twelve months is around 3.44%, more than ADI's 1.85% yield.
| TTM | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABBV AbbVie Inc. | 3.44% | 3.49% | 3.82% | 3.49% | 3.84% | 4.41% | 4.83% | 3.89% | 2.65% | 3.64% | 3.41% | 2.54% |
ADI Analog Devices, Inc. | 1.85% | 1.73% | 1.73% | 1.85% | 1.57% | 1.68% | 1.82% | 2.24% | 2.02% | 2.31% | 2.89% | 2.67% |
Drawdowns
ABBV vs. ADI - Drawdown Comparison
The maximum ABBV drawdown since its inception was -45.09%, smaller than the maximum ADI drawdown of -82.88%. Use the drawdown chart below to compare losses from any high point for ABBV and ADI. For additional features, visit the drawdowns tool.
Volatility
ABBV vs. ADI - Volatility Comparison
The current volatility for AbbVie Inc. (ABBV) is 10.10%, while Analog Devices, Inc. (ADI) has a volatility of 21.36%. This indicates that ABBV experiences smaller price fluctuations and is considered to be less risky than ADI based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ABBV vs. ADI - Financials Comparison
This section allows you to compare key financial metrics between AbbVie Inc. and Analog Devices, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABBV vs. ADI - Profitability Comparison
ABBV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a gross profit of 11.20B and revenue of 13.34B. Therefore, the gross margin over that period was 83.9%.
ADI - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on May 2025, Analog Devices, Inc. reported a gross profit of 1.43B and revenue of 2.42B. Therefore, the gross margin over that period was 59.0%.
ABBV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported an operating income of 3.73B and revenue of 13.34B, resulting in an operating margin of 28.0%.
ADI - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on May 2025, Analog Devices, Inc. reported an operating income of 491.31M and revenue of 2.42B, resulting in an operating margin of 20.3%.
ABBV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, AbbVie Inc. reported a net income of 1.29B and revenue of 13.34B, resulting in a net margin of 9.6%.
ADI - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on May 2025, Analog Devices, Inc. reported a net income of 391.32M and revenue of 2.42B, resulting in a net margin of 16.2%.